Research ArticleArticle

Effectiveness of Tumor Necrosis Factor Inhibitors in Combination with Various csDMARD in the Treatment of Rheumatoid Arthritis: Data from the DREAM Registry

Sofie H.M. Manders, Wietske Kievit, Tim L.T.A. Jansen, Jan N. Stolk, Henk Visser, Annemarie M. Schilder, Harald E. Vonkeman, Eddy Adang, Mart A.F.J. van de Laar and Piet L.C.M. van Riel
The Journal of Rheumatology October 2016, 43 (10) 1787-1794; DOI: https://doi.org/10.3899/jrheum.151014

Article Information

vol. 43 no. 10 1787-1794
DOI 
https://doi.org/10.3899/jrheum.151014
PubMed 
27481900
Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Accepted for publication June 15, 2016
  • Published online October 1, 2016.

Article Versions

Copyright & Usage 
© 2016

Author Information

  1. Sofie H.M. Manders⇑,
  2. Wietske Kievit,
  3. Tim L.T.A. Jansen,
  4. Jan N. Stolk,
  5. Henk Visser,
  6. Annemarie M. Schilder,
  7. Harald E. Vonkeman,
  8. Eddy Adang,
  9. Mart A.F.J. van de Laar and
  10. Piet L.C.M. van Riel
  1. From the Department of IQ Healthcare, the Department of Health Evidence, the Department of Rheumatic Diseases, Radboud University Medical Center, Nijmegen; Rheumatology, Ziekenhuis Gelderse Vallei, Ede; Rheumatology, Rijnstate, Arnhem; Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Arthritis Centre Twente, Rheumatology and Clinical Immunology, Medical Spectrum Twente, Enschede, the Netherlands.
  2. S.H. Manders, MSc, Department of IQ Healthcare, Radboud University Medical Center; W. Kievit, PhD, Department of Health Evidence, Radboud University Medical Center; T.L. Jansen, PhD, Department of Rheumatic Diseases, Radboud University Medical Center; J.N. Stolk, PhD, Rheumatology, Ziekenhuis Gelderse Vallei; H. Visser, PhD, Rheumatology, Rijnstate; A.M. Schilder, MD, Rheumatology, Medical Centre Leeuwarden; H.E. Vonkeman, PhD, Arthritis Centre Twente, Rheumatology and Clinical Immunology, Medical Spectrum Twente; E. Adang, PhD, Department of Health Evidence, Radboud University Medical Center; M.A. van de Laar, Professor, Arthritis Centre Twente, Rheumatology and Clinical Immunology, Medical Spectrum Twente; P.L. van Riel, Professor, Department of IQ Healthcare, Radboud University Medical Center.
  1. Address correspondence to S.H. Manders, Radboudumc, IQ Healthcare 114, PO Box 9101, 6500 HB Nijmegen, the Netherlands. E-mail: sofie.manders{at}radboudumc.nl

Article usage

Article usage: July 2016 to May 2022

AbstractFullPdf
Jul 2016301
Aug 2016317074
Sep 20161031731
Oct 201613013193
Nov 20161971329
Dec 2016156411
Jan 2017119915
Feb 20172401311
Mar 20171151312
Apr 20176646
May 20174298
Jun 20174236
Jul 20176179
Aug 20175311
Sep 20173744
Oct 20173943
Nov 20174043
Dec 20174222
Jan 20184176
Feb 20183321
Mar 20183831
Apr 20185251
May 20184143
Jun 20182433
Jul 20183211
Aug 20182623
Sep 20183900
Oct 20183233
Nov 20183032
Dec 20182831
Jan 20194156
Feb 20192200
Mar 20192121
Apr 20193533
May 20191522
Jun 20192618
Jul 20193411
Aug 20194611
Sep 20193723
Oct 20193544
Nov 20193942
Dec 20192911
Jan 20202140
Feb 20203165
Mar 202002512
Apr 20203204
May 20205180
Jun 2020487
Jul 20205118
Aug 2020101714
Sep 202072010
Oct 20209119
Nov 2020787
Dec 20205102
Jan 2021297
Feb 202111278
Mar 20212811
Apr 20213134
May 20212402
Jun 20213121
Jul 2021063
Aug 2021086
Sep 20210123
Oct 2021385
Nov 2021166
Dec 20212130
Jan 2022365
Feb 20221043
Mar 20222231
Apr 202222513
May 20221147

Statistics from Altmetric.com

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section

Keywords

RHEUMATOID ARTHRITIS
TUMOR NECROSIS FACTOR INHIBITOR
DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
METHOTREXATE

Keywords